Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VLS-1488 by Volastra Therapeutics for Ovarian Cancer: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...
VLS-1488 by Volastra Therapeutics for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Head And Neck Squamous Cell Carcinoma...
VLS-1488 by Volastra Therapeutics for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According to...
VLS-1488 by Volastra Therapeutics for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Esophageal Squamous Cell Carcinoma (ESCC). According...
VLS-1488 by Volastra Therapeutics for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to...
VLS-1488 by Volastra Therapeutics for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Squamous Non-Small Cell Lung Cancer. According...
VLS-1488 by Volastra Therapeutics for Adenocarcinoma: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Adenocarcinoma. According to GlobalData, Phase II...
VLS-1488 by Volastra Therapeutics for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Transitional Cell Cancer (Urothelial Cell Cancer)....
VLS-1488 by Volastra Therapeutics for Uterine Cancer: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Uterine Cancer. According to GlobalData, Phase...
VLS-1488 by Volastra Therapeutics for Endometrial Cancer: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase...
VLS-1488 by Volastra Therapeutics for Solid Tumor: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
VLS-1488 by Volastra Therapeutics for Gastric Cancer: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
VLS-1488 by Volastra Therapeutics for Colorectal Cancer: Likelihood of Approval
VLS-1488 is under clinical development by Volastra Therapeutics and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...